Cargando…

At the crossroads between early or delayed antiretroviral therapy initiation during tuberculosis/human immunodeficiency virus coinfection

Detalles Bibliográficos
Autor principal:	Moreira, José Alfredo de Sousa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428177/ https://www.ncbi.nlm.nih.gov/pubmed/25066051 http://dx.doi.org/10.1016/j.bjid.2014.06.003

Ejemplares similares

Reply to “At the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection”
por: Saraceni, Valeria, et al.
Publicado: (2014)

Tuberculosis and human immunodeficiency virus coinfection complicated by immune reconstitution inflammatory syndrome
por: Barman, Bhupen, et al.
Publicado: (2022)

Adherence to antiretrovirals in people coinfected with the human immunodeficiency virus and tuberculosis
por: Lemos, Larissa de Araújo, et al.
Publicado: (2016)

Low rates of Hepatitis B and Human Immunodeficiency Virus coinfection in rural northern Tanzania
por: Debes, Jose D., et al.
Publicado: (2015)

The impact of hepatitis C virus and human immunodeficiency virus coinfection on survival in patients with hepatocellular carcinoma
por: Spartalis, Eleftherios, et al.
Publicado: (2017)

Dermatological manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome in era of highly active antiretroviral therapy
por: Bosamiya, Sanjay S., et al.
Publicado: (2014)

Hypercalcemia during initiation of antiretroviral therapy in human immunodeficiency virus and Leishmania coinfection: A case report
por: Yu, Tammy, et al.
Publicado: (2023)

Miliary Tuberculosis Coinfection with Human Immunodeficiency Virus
por: Esteve, Erika, et al.
Publicado: (2010)

Discovery of CD3(+)CD19(+) cells, a novel lymphocyte subset with a potential role in human immunodeficiency virus‐Mycobacterium tuberculosis coinfection, using mass cytometry
por: Li, Qian, et al.
Publicado: (2021)

High Tuberculosis and HIV Coinfection Rate, Johannesburg
por: John, Melanie-Anne, et al.
Publicado: (2007)

Seroprevalence of hepatitis B and syphilis co-infection in human immunodeficiency virus-positive antiretroviral therapy attendees and human immunodeficiency virus-negative sexually transmitted infection attendees
por: Agrawal, Arti, et al.
Publicado: (2016)

Predictors of human immunodeficiency virus and tuberculosis co-infection
por: Kandi, Venkataramana
Publicado: (2015)

Metabolic syndrome and cardiovascular disease risk assessment among human immunodeficiency virus-infected individuals on antiretroviral therapy
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2019)

Human immunodeficiency virus coinfection with drug-resistant Mycobacterium tuberculosis
por: Zaharia-Kézdi, Iringó Erzsébet, et al.
Publicado: (2013)

Coinfection of hepatitis B and hepatitis C in human immunodeficiency virus infected patients in a tertiary care hospital in North West India
por: Hooja, Saroj, et al.
Publicado: (2012)

Early Initiation of Antiretroviral Therapy Among Young Children: A Long Way to Go
por: Doherty, Tanya, et al.
Publicado: (2015)

Impact of Raltegravir or Efavirenz on Cell-Associated Human Immunodeficiency Virus-1 (HIV-1) Deoxyribonucleic Acid and Systemic Inflammation in HIV-1/Tuberculosis Coinfected Adults Initiating Antiretroviral Therapy
por: Delagreverie, Héloïse M, et al.
Publicado: (2020)

Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis
por: Kay, Alexander, et al.
Publicado: (2022)

HIV and Hepatitis C Virus Coinfection, Cameroon
por: Laurent, Christian, et al.
Publicado: (2007)

Immune restoration in human immunodeficiency virus and hepatitis C virus coinfected patients after highly active antiretroviral therapy
por: Antonello, Vicente Sperb, et al.
Publicado: (2013)

Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2016)

Dipstick urinalysis should be documented prior to initiating antiretroviral therapy
por: Harry, Tubonye C.
Publicado: (2012)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy
por: Salvadori, Nicolas, et al.
Publicado: (2017)

Aetiology, Clinical Presentation, and Outcome of Meningitis in Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis
por: Bhagwan, Smita, et al.
Publicado: (2011)

Realigning global health governance: WHO at a crossroads
por: Torres, Irene, et al.
Publicado: (2020)

Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Martinello, Marianne, et al.
Publicado: (2016)

High-risk behavioral tendencies in human immunodeficiency virus-positive patients on antiretroviral therapy: A 5-year retrospective study from a tertiary care center
por: Nair, S. Pradeep
Publicado: (2022)

Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment
por: Sinha, Sanjeev, et al.
Publicado: (2012)

Genes at the Crossroad of Primary Immunodeficiencies and Cancer
por: Derpoorter, Charlotte, et al.
Publicado: (2018)

Lymphocutaneous Nocardiosis in a Patient With Human Immunodeficiency/Tuberculosis Coinfection
por: Singh, Ranjan K
Publicado: (2022)

Cognitive Impairment among Persons of Rural Background Living with Human Immunodeficiency Virus Infection on Antiretroviral Therapy: A Study from a Tertiary Care Centre of North India
por: Mahajan, Vikram K., et al.
Publicado: (2016)

Coinfection between SARS‐CoV‐2 and other respiratory tract viruses
por: Özdemir, Öner, et al.
Publicado: (2022)

Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients
por: Lo Re, Vincent, et al.
Publicado: (2015)

Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009)

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?
por: van Griensven, Johan, et al.
Publicado: (2018)

Converging Epidemics: A Narrative Review of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) Coinfection
por: Bhatt, Asmi, et al.
Publicado: (2023)

Nucleoside reverse transcriptase inhibitors (zidovudine and stavudine) side-effects in people living with human immunodeficiency virus/acquired immunodeficiency syndrome attending the antiretroviral treatment center of B.J. Medical College and Civil Hospital at Ahmedabad, Gujarat, India
por: Shah, Asha N., et al.
Publicado: (2013)

Seroprevalence of Human Immunodeficiency Virus and the rising epidemic of Human Immunodeficiency Virus among injecting drug users of district Patiala
por: Grewal, Udhayvir Singh, et al.
Publicado: (2015)

To alert coinfection of COVID-19 and dengue virus in developing countries in the dengue-endemic area
por: Wu, Di, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tb1qb4jjqo5mcob4fm241fsbru